451 related articles for article (PubMed ID: 18811224)
21. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
22. Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study.
Kist-van Holthe JE; Ho PL; Stablein D; Harmon WE; Baum MA
Pediatr Transplant; 2005 Jun; 9(3):305-10. PubMed ID: 15910385
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
[TBL] [Abstract][Full Text] [Related]
24. [The assessment of nephroblastoma therapy results using the SIOP 92-01 protocol].
Madziara W; Bohosiewicz J
Wiad Lek; 1998; 51 Suppl 3():106-9. PubMed ID: 9814117
[TBL] [Abstract][Full Text] [Related]
25. Wilms' tumor: past, present and (possibly) future.
Spreafico F; Bellani FF
Expert Rev Anticancer Ther; 2006 Feb; 6(2):249-58. PubMed ID: 16445377
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.
Lin RY; Argenta PA; Sullivan KM; Adzick NS
Clin Cancer Res; 1995 Mar; 1(3):327-31. PubMed ID: 9815988
[TBL] [Abstract][Full Text] [Related]
27. Primary hepatic metastases in nephroblastoma--a report of the SIOP/GPOH Study.
Szavay P; Luithle T; Graf N; Furtwängler R; Fuchs J
J Pediatr Surg; 2006 Jan; 41(1):168-72; discussion 168-72. PubMed ID: 16410128
[TBL] [Abstract][Full Text] [Related]
28. The advantages of preoperative therapy in Wilms' tumour. A summarised report on clinical trials conducted by the International Society of Paediatric Oncology (SIOP).
Bürger D; Moorman-Voestermans CG; Mildenberger H; Lemerle J; Voûte PA; Tournade MF; Rodary C; Delemarre JF; Sandstedt B; Sarrazin D
Z Kinderchir; 1985 Jun; 40(3):170-5. PubMed ID: 2994320
[TBL] [Abstract][Full Text] [Related]
29. Cystic nephroma, cystic partially differentiated nephroblastoma and cystic Wilms' tumor in children: a spectrum with therapeutic dilemmas.
van den Hoek J; de Krijger R; van de Ven K; Lequin M; van den Heuvel-Eibrink MM
Urol Int; 2009; 82(1):65-70. PubMed ID: 19172100
[TBL] [Abstract][Full Text] [Related]
30. Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies.
Reinhard H; Schmidt A; Furtwängler R; Leuschner I; Rübe C; Von Schweinitz D; Zoubek A; Niggli F; Graf N
Oncol Rep; 2008 Aug; 20(2):463-7. PubMed ID: 18636212
[TBL] [Abstract][Full Text] [Related]
31. [Wilms' tumors, 12 case reports].
Chacar HR; Asmar N; Bou-Saba R; Korkmaz G; Taleb N; Majdalani E; Saade M; Kyriakos S
J Med Liban; 1992; 40(2):96-9. PubMed ID: 1339890
[TBL] [Abstract][Full Text] [Related]
32. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
Suita S; Kinoshita Y; Tajiri T; Hara T; Tsuneyoshi M; Mizote H; Inada H; Takamatsu H; Kawano Y; Inomata Y; Nagasaki A; Ono Y; Handa N; Okamura J; Ishii E; Kawakami K;
J Pediatr Surg; 2006 Sep; 41(9):1501-5. PubMed ID: 16952581
[TBL] [Abstract][Full Text] [Related]
34. [Wilms tumor in the adult].
Calvo Rodríguez M; Fírvida Pérez JL; Vega Vázquez F; Salgado Fernández M; García Mata J; Rubén Rodríguez M; Barreiro Mouro A
Arch Esp Urol; 2001 May; 54(4):370-4. PubMed ID: 11455774
[TBL] [Abstract][Full Text] [Related]
35. P-glycoprotein expression, tumor weight, age, and relapse in patients with stage I and II favorable-histology Wilms' tumor.
Teixeira RA; Odone-Filho V; de Camargo B; Zerbini MC; Fillipi R; Alencar A; Cristofani L
Pediatr Hematol Oncol; 2011 Apr; 28(3):194-202. PubMed ID: 21214406
[TBL] [Abstract][Full Text] [Related]
36. Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: a UK Children's Cancer Study Group, Wilms' Tumour Working Group Study.
Nicolin G; Taylor R; Baughan C; Shannon R; Stevens S; Richardson D; Kelsey A; Pritchard-Jones K; Mitchell C
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):175-80. PubMed ID: 17980506
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
[TBL] [Abstract][Full Text] [Related]
38. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
Mathew P; Douglass EC; Jones D; Valentine M; Valentine V; Rowe S; Shapiro DN
Med Pediatr Oncol; 1996 Jul; 27(1):3-7. PubMed ID: 8614388
[TBL] [Abstract][Full Text] [Related]
39. Surgery of cavoatrial tumor thrombus in nephroblastoma: a report of the SIOP/GPOH study.
Szavay P; Luithle T; Semler O; Graf N; Fuchs J
Pediatr Blood Cancer; 2004 Jul; 43(1):40-5. PubMed ID: 15170888
[TBL] [Abstract][Full Text] [Related]
40. Wilms' tumour: a comparison of surgical aspects in patients with or without pre-operative chemotherapy.
Safdar CA; Aslam M; Awan SH; Ahmed I; Badshah S
J Coll Physicians Surg Pak; 2006 Aug; 16(8):521-4. PubMed ID: 16899180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
